Annual FCF:
-$37.85M+$11.44M(+23.21%)Summary
- As of today, XERS annual free cash flow is -$37.85 million, with the most recent change of +$11.44 million (+23.21%) on December 31, 2024.
- During the last 3 years, XERS annual free cash flow has risen by +$58.77 million (+60.83%).
- XERS annual free cash flow is now -134.77% below its all-time high of -$16.12 million, reached on December 31, 2016.
Performance
XERS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$97.00K+$9.95M(+99.03%)Summary
- As of today, XERS quarterly free cash flow is -$97.00 thousand, with the most recent change of +$9.95 million (+99.03%) on June 30, 2025.
- Over the past year, XERS quarterly free cash flow has increased by +$10.65 million (+99.10%).
- XERS quarterly free cash flow is now -101.32% below its all-time high of $7.34 million, reached on December 31, 2023.
Performance
XERS Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$16.78M+$10.65M(+38.82%)Summary
- As of today, XERS TTM free cash flow is -$16.78 million, with the most recent change of +$10.65 million (+38.82%) on June 30, 2025.
- Over the past year, XERS TTM free cash flow has increased by +$22.05 million (+56.79%).
- XERS TTM free cash flow is now -334.55% below its all-time high of -$3.86 million, reached on March 31, 2017.
Performance
XERS TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
XERS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +23.2% | +99.1% | +56.8% |
| 3Y3 Years | +60.8% | +99.5% | +86.2% |
| 5Y5 Years | +64.1% | +99.6% | +83.2% |
XERS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +63.4% | -101.3% | +99.6% | at high | +85.6% |
| 5Y | 5-Year | at high | +64.1% | -101.3% | +99.8% | at high | +86.2% |
| All-Time | All-Time | -134.8% | +64.1% | -101.3% | +99.8% | -334.6% | +86.2% |
XERS Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$97.00K(+99.0%) | -$16.78M(+38.8%) |
| Mar 2025 | - | -$10.04M(-672.3%) | -$27.43M(+27.5%) |
| Dec 2024 | -$37.85M(+23.2%) | $1.75M(+120.9%) | -$37.85M(-17.3%) |
| Sep 2024 | - | -$8.39M(+21.9%) | -$32.27M(+16.9%) |
| Jun 2024 | - | -$10.74M(+47.5%) | -$38.83M(+10.5%) |
| Mar 2024 | - | -$20.47M(-378.9%) | -$43.38M(+12.0%) |
| Dec 2023 | -$49.29M(+52.3%) | $7.34M(+149.1%) | -$49.29M(+32.4%) |
| Sep 2023 | - | -$14.96M(+2.2%) | -$72.88M(+3.9%) |
| Jun 2023 | - | -$15.29M(+42.0%) | -$75.85M(+6.8%) |
| Mar 2023 | - | -$26.38M(-62.3%) | -$81.38M(+21.3%) |
| Dec 2022 | -$103.42M(-7.0%) | -$16.25M(+9.4%) | -$103.42M(+11.0%) |
| Sep 2022 | - | -$17.93M(+13.9%) | -$116.24M(+4.1%) |
| Jun 2022 | - | -$20.82M(+57.0%) | -$121.23M(-0.5%) |
| Mar 2022 | - | -$48.41M(-66.5%) | -$120.64M(-24.9%) |
| Dec 2021 | -$96.62M | -$29.08M(-26.9%) | -$96.62M(-22.9%) |
| Sep 2021 | - | -$22.92M(-13.2%) | -$78.64M(-8.2%) |
| Jun 2021 | - | -$20.24M(+17.0%) | -$72.68M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$24.39M(-119.8%) | -$76.35M(+5.7%) |
| Dec 2020 | -$80.94M(+23.3%) | -$11.09M(+34.6%) | -$80.94M(+18.8%) |
| Sep 2020 | - | -$16.96M(+29.0%) | -$99.66M(+12.3%) |
| Jun 2020 | - | -$23.91M(+17.5%) | -$113.64M(-0.5%) |
| Mar 2020 | - | -$28.97M(+2.8%) | -$113.07M(-7.2%) |
| Dec 2019 | -$105.45M(-82.5%) | -$29.82M(+3.7%) | -$105.45M(-11.9%) |
| Sep 2019 | - | -$30.95M(-32.7%) | -$94.22M(-17.8%) |
| Jun 2019 | - | -$23.33M(-9.3%) | -$79.96M(-12.6%) |
| Mar 2019 | - | -$21.35M(-14.9%) | -$71.00M(-22.9%) |
| Dec 2018 | -$57.79M(-127.8%) | -$18.59M(-11.4%) | -$57.79M(-19.1%) |
| Sep 2018 | - | -$16.69M(-16.1%) | -$48.54M(-29.6%) |
| Jun 2018 | - | -$14.38M(-76.7%) | -$37.45M(-62.3%) |
| Mar 2018 | - | -$8.14M(+12.8%) | -$23.08M(-22.8%) |
| Dec 2017 | -$25.36M(-57.3%) | -$9.34M(-66.7%) | -$18.80M(-98.7%) |
| Sep 2017 | - | -$5.60M(-45.1%) | -$9.46M(-145.1%) |
| Mar 2017 | - | -$3.86M | -$3.86M |
| Dec 2016 | -$16.12M | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual free cash flow year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly free cash flow year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM free cash flow year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual free cash flow?
The current annual free cash flow of XERS is -$37.85M
What is the all-time high annual free cash flow for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual free cash flow is -$16.12M
What is Xeris Biopharma Holdings, Inc. annual free cash flow year-on-year change?
Over the past year, XERS annual free cash flow has changed by +$11.44M (+23.21%)
What is Xeris Biopharma Holdings, Inc. quarterly free cash flow?
The current quarterly free cash flow of XERS is -$97.00K
What is the all-time high quarterly free cash flow for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly free cash flow is $7.34M
What is Xeris Biopharma Holdings, Inc. quarterly free cash flow year-on-year change?
Over the past year, XERS quarterly free cash flow has changed by +$10.65M (+99.10%)
What is Xeris Biopharma Holdings, Inc. TTM free cash flow?
The current TTM free cash flow of XERS is -$16.78M
What is the all-time high TTM free cash flow for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM free cash flow is -$3.86M
What is Xeris Biopharma Holdings, Inc. TTM free cash flow year-on-year change?
Over the past year, XERS TTM free cash flow has changed by +$22.05M (+56.79%)